RDHL - RedHill Biopharma Ltd.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts3335
Avg. Estimate-0.46-0.44-1.73-0.32
Low Estimate-0.54-0.51-2.01-1.73
High Estimate-0.34-0.33-1.282.54
Year Ago EPS-0.5-0.6-2.6-1.73
Revenue EstimateCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
No. of Analysts4456
Avg. Estimate2.32M2.67M12.39M42.41M
Low Estimate1.89M2.17M9.42M15M
High Estimate2.5M3M16.6M141.4M
Year Ago SalesN/A483k4.01M12.39M
Sales Growth (year/est)N/A452.80%209.20%242.30%
Earnings History3/30/20176/29/20179/29/201712/30/2017
EPS Est.-0.57-0.58-0.63-0.6
EPS Actual-0.5-0.60.09-0.5
Difference0.07-0.020.720.1
Surprise %12.30%-3.40%114.30%16.70%
EPS TrendCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Current Estimate-0.46-0.44-1.73-0.32
7 Days Ago-0.46-0.44-1.73-0.32
30 Days Ago-0.46-0.44-1.73-0.36
60 Days Ago-0.43-0.42-1.7-0.4
90 Days Ago-0.63-0.64-0.77-0.32
EPS RevisionsCurrent Qtr. (Mar 2018)Next Qtr. (Jun 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesRDHLIndustrySectorS&P 500
Current Qtr.8.00%N/AN/A0.43
Next Qtr.26.70%N/AN/A0.41
Current Year33.50%N/AN/A0.21
Next Year81.50%N/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.12
Past 5 Years (per annum)N/AN/AN/AN/A